SAI LIFE SCIENCES LIMITED (SAILIFE) financials

SAI LIFE SCIENCES LIMITED (SAILIFE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1999, Sai Life SciencesLtd carries out contract research and manufacturing activities for customersengaged in pharmaceutical and biotechnology industries[1]

Market Cap: ₹31,253Cr.
Current Price: ₹1,471
Stock P/E: 86.7
ROE: 14.9%
ROCE: 19.2%
Book Value: ₹118
Dividend Yield: 0.00%
52W High / Low: ₹1,697/784

In Jun 2026, SAI LIFE SCIENCES LIMITED (SAILIFE) reported sales ₹547 Cr and net profit ₹71 Cr.

Annual TTM: sales ₹2,217 Cr, net profit ₹354 Cr.

Shareholding: Promoters 34.50% (Sep 2026), FIIs 19.91% (Sep 2026), DIIs 32.32% (Sep 2026), Public 13.25% (Sep 2026), No. of Shareholders 1,43,124% (Sep 2026).

SAILIFE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	382	429	567	483	527	549	594	547
Expenses	281	317	413	370	387	370	426	407
Operating Profit	101	111	154	113	140	179	168	140
OPM %	26%	26%	27%	23%	27%	33%	28%	26%
Other Income	10	9	10	10	15	0	16	4
Interest	19	22	9	11	8	8	6	6
Depreciation	33	31	34	34	36	41	41	42
Profit before tax	58	68	120	78	111	130	137	95
Tax %	25%	25%	25%	25%	25%	25%	25%	25%
Net Profit	44	51	90	58	83	98	103	71
EPS in Rs	—	2.45	4.32	2.80	3.95	4.62	4.84	3.36
Raw PDF	—	—	—	—	—	—	—	—

SAILIFE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	725	751	841	1,157	1,419	1,642	2,153	2,217
Expenses	556	587	716	990	1,131	1,248	1,551	1,590
Operating Profit	170	164	125	167	288	394	602	627
OPM %	23%	22%	15%	14%	20%	24%	28%	28%
Other Income	18	27	28	27	29	36	40	35
Interest	21	32	51	74	81	72	34	28
Depreciation	52	72	80	88	107	126	152	160
Profit before tax	114	88	22	33	129	232	456	474
Tax %	30%	25%	30%	26%	26%	25%	25%	—
Net Profit	80	65	16	24	95	173	341	354
EPS in Rs	—	—	—	—	—	8.32	16.12	16.77
Dividend Payout %	0%	0%	444%	279%	0%	0%	0%	—

SAILIFE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	18	18	18	18	21	21
Reserves	700	778	850	873	895	993	2,147	2,487
Borrowings	250	304	637	752	869	868	287	223
Other Liabilities	246	291	312	464	349	361	682	872
Total Liabilities	1,212	1,389	1,816	2,106	2,131	2,240	3,137	3,603
Fixed Assets	373	617	659	701	923	1,074	1,378	1,705
CWIP	116	79	236	345	151	107	124	270
Investments	0	22	63	64	80	80	114	163
Other Assets	722	671	858	996	977	979	1,521	1,465
Total Assets	1,212	1,389	1,816	2,106	2,131	2,240	3,137	3,603

SAILIFE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	127	109	-26	88	221	251	330	495
Cash from Investing Activity	-158	-259	-279	-95	-111	-190	-565	-393
Cash from Financing Activity	268	-1	304	81	-190	-85	314	-109
Net Cash Flow	237	-152	-2	75	-80	-24	80	-7
Free Cash Flow	-30	-139	-267	-109	156	72	-33	-94
CFO/OP	89%	75%	-6%	77%	135%	92%	89%	89%

SAILIFE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	35.23%	35.16%	35.15%	34.95%	34.70%	34.61%	34.53%	34.50%
FIIs	11.72%	12.36%	14.57%	22.50%	21.41%	21.17%	19.65%	19.91%
DIIs	11.95%	13.26%	21.64%	29.92%	31.41%	31.54%	32.71%	32.32%
Public	41.08%	39.21%	28.64%	12.65%	12.49%	12.69%	13.11%	13.25%
No. of Shareholders	1,81,122	1,40,677	1,26,380	1,19,705	1,14,820	1,17,527	1,25,096	1,43,124

SAILIFE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	123	136	98	103	87	67	78	63
Inventory Days	86	77	124	185	123	73	96	98
Days Payable	208	247	244	284	176	114	270	200
Cash Conversion Cycle	0	-34	-21	4	35	25	-96	-40
Working Capital Days	55	32	60	49	42	20	69	68
ROCE %	—	13%	9%	4%	6%	11%	14%	19%

SAILIFEUpdated 13 Oct 2026, 6:02

Sai Life Sciences Limited

SAILIFEUpdated 13 Oct 2026, 6:02

Market Cap

₹31,253Cr.

Current Price

₹1,471

High / Low

₹1,697/784

Stock P/E

86.7

ROE14.9%

ROCE19.2%

Book Value₹118

Face Value₹1.00

Dividend Yield0.00%

About

Incorporated in 1999, Sai Life SciencesLtd carries out contract research and manufacturing activities for customersengaged in pharmaceutical and biotechnology industries[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Dec 2023	373	22	279	11	28	54	26	40	—
Mar 2024	428	19	301	4	28	83	26	62	—
Jun 2024	264	20	240	8	28	-15	-25	-11	—
Sep 2024	382	19	281	10	33	58	25	44	—
Dec 2024	429	22	317	9	31	68	25	51	2.45
Mar 2025	567	9	413	10	34	120	25	90	4.32
Jun 2025	483	11	370	10	34	78	25	58	2.8
Sep 2025	527	8	387	15	36	111	25	83	3.95
Dec 2025	549	8	370	0	41	130	25	98	4.62
Mar 2026	594	6	426	16	41	137	25	103	4.84
Jun 2026	547	6	407	4	42	95	25	71	3.36

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2019	695	24	520	6	44	112	35	73	—
Mar 2020	725	21	556	18	52	114	30	80	—
Mar 2021	751	32	587	27	72	88	25	65	—
Mar 2022	841	51	716	28	80	22	30	16	—
Mar 2023	1157	74	990	27	88	33	26	24	—
Mar 2024	1419	81	1131	29	107	129	26	95	—
Mar 2025	1642	72	1248	36	126	232	25	173	8.32
Mar 2026	2153	34	1551	40	152	456	25	341	16.12
TTM	2217	28	1590	35	160	474	—	354	16.77

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	34.5%
FIIs	19.91%
DIIs	32.32%
Public	13.25%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2024	35.23%	11.72%	11.95%	41.08%
Mar 2025	35.16%	12.36%	13.26%	39.21%
Jun 2025	35.15%	14.57%	21.64%	28.64%
Sep 2025	34.95%	22.5%	29.92%	12.65%
Dec 2025	34.7%	21.41%	31.41%	12.49%
Mar 2026	34.61%	21.17%	31.54%	12.69%
Jun 2026	34.53%	19.65%	32.71%	13.11%
Sep 2026	34.5%	19.91%	32.32%	13.25%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2019	16	700	250	246	1212	373	116	0	722	1212
Mar 2020	16	778	304	291	1389	617	79	22	671	1389
Mar 2021	18	850	637	312	1816	659	236	63	858	1816
Mar 2022	18	873	752	464	2106	701	345	64	996	2106
Mar 2023	18	895	869	349	2131	923	151	80	977	2131
Mar 2024	18	993	868	361	2240	1074	107	80	979	2240
Mar 2025	21	2147	287	682	3137	1378	124	114	1521	3137
Mar 2026	21	2487	223	872	3603	1705	270	163	1465	3603

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2019	127	-158	268	237
Mar 2020	109	-259	-1	-152
Mar 2021	-26	-279	304	-2
Mar 2022	88	-95	81	75
Mar 2023	221	-111	-190	-80
Mar 2024	251	-190	-85	-24
Mar 2025	330	-565	314	80
Mar 2026	495	-393	-109	-7

Key ratios

Historical financial ratios

Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	123	136	98	103	87	67	78	63
Inventory Days	86	77	124	185	123	73	96	98
Days Payable	208	247	244	284	176	114	270	200
Cash Conversion Cycle	0	-34	-21	4	35	25	-96	-40
Working Capital Days	55	32	60	49	42	20	69	68
ROCE %	—	13%	9%	4%	6%	11%	14%	19%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SAI LIFE SCIENCES LIMITED (SAILIFE)?

The reported market capitalisation for SAI LIFE SCIENCES LIMITED (SAILIFE) is ₹31,253Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SAILIFE?

The current price shown for SAI LIFE SCIENCES LIMITED (SAILIFE) on Fincrux is ₹1,471 with a 52-week high/low of ₹1,697/784.

What is the P/E ratio of SAI LIFE SCIENCES LIMITED (SAILIFE)?

The stock P/E for SAI LIFE SCIENCES LIMITED (SAILIFE) is 86.7 on Fincrux, with ROE at 14.9% and ROCE at 19.2%.

What were SAILIFE latest quarterly results?

For Jun 2026, SAI LIFE SCIENCES LIMITED (SAILIFE) reported sales ₹547 Cr and net profit ₹71 Cr (figures in ₹ crore unless noted).

What are SAILIFE annual sales and net profit?

For TTM, SAI LIFE SCIENCES LIMITED (SAILIFE) shows sales of ₹2,217 Cr and net profit of ₹354 Cr on the Fincrux profit & loss statement.

Who owns SAI LIFE SCIENCES LIMITED (SAILIFE)?

Latest shareholding for SAI LIFE SCIENCES LIMITED (SAILIFE) on Fincrux: Promoters 34.50% (Sep 2026), FIIs 19.91% (Sep 2026), DIIs 32.32% (Sep 2026), Public 13.25% (Sep 2026), No. of Shareholders 1,43,124% (Sep 2026).

Where can I find SAI LIFE SCIENCES LIMITED (SAILIFE) financials?

SAI LIFE SCIENCES LIMITED (SAILIFE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SAILIFE balance sheet and cash flow?

Yes. The SAI LIFE SCIENCES LIMITED (SAILIFE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 6:02